Interaction between BDNF and Serotonin: Role in Mood Disorders
The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Abstract
Brain-derived neurotrophic factor (BDNF) and serotonin (5-hydroxytryptamine, 5-HT) are two seemingly distinct signaling systems that play regulatory roles in many neuronal functions including survival, neurogenesis, and synaptic plasticity. A common feature of the two systems is their ability to regulate the development and plasticity of neural circuits involved in mood disorders such as depression and anxiety. BDNF promotes the survival and differentiation of 5-HT neurons. Conversely, administration of antidepressant selective serotonin reuptake inhibitors (SSRIs) enhances BDNF gene expression. There is also evidence for synergism between the two systems in affective behaviors and genetic epitasis between BDNF and the serotonin transporter genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BDNF+/− mice show less dendritic branching as well as dendritic retraction and simplification in CA381 and DG80 and dysregulation of BDNF/TrkB pathways has been reported in MDD and animal models of depression78, 169-171.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [169]
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 4×
“Analysis of the promoter region of 5-HTT has revealed a polymorphism that results in allelic variation in functional 5-HTT expression (”
BackgroundInfluentialNeurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394 · cited 2×
“…survival of peripheral neurons, BDNF is now recognized as a plethoric factor able to regulate a wide repertoire of functions, including neuronal survival, migration, phenotypic differentiation, axonal and dendritic growth, and synapse formation (Huang and Reichardt, 2001; Lewin and Barde, 1996).”
BackgroundRequirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 2×
“Like BDNF, alterations in 5-HT signaling have demonstrable effects on synaptic plasticity and adult neurogenesis in the hippocampus (Brezun and Daszuta, 1999; Gould, 1999; Santarelli et al, 2003; Djavadian, 2004).”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 2×
“Human subjects carrying the Val66Met SNP exhibit deficits in short-term episodic memory and show abnormal hippocampal activation (”
BackgroundSelf-citationA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 7×
“…76 .............................................................................................................................................. Neuropsychopharmacology REVIEWS REVIEW has lagged (Duman and Monteggia, 2006).”
BackgroundInfluentialNestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“Importantly, antidepressants and the mood stabilizer lithium have been shown to elicit an increase in hippocampal neurogenesis (Chen et al, 2000; Malberg et al, 2000).”
BackgroundTrk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537 · cited 2×
“Binding of mature BDNF (mBDNF) to TrkB triggers tyrosine phosphorylation in its cytoplasmic domain, leading to activation of at least three signaling pathways: MEK–MAPK, phosphatidylinositol-3-kinase (PI3-K) and phospholipase C-g (PLC-g) (Kaplan and Miller, 2000; Chao, 2003; Huang and Reichardt, 2003).”
BackgroundNeurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298 · cited 2×
“Binding of mature BDNF (mBDNF) to TrkB triggers tyrosine phosphorylation in its cytoplasmic domain, leading to activation of at least three signaling pathways: MEK–MAPK, phosphatidylinositol-3-kinase (PI3-K) and phospholipase C-g (PLC-g) (Kaplan and Miller, 2000; Chao, 2003; Huang and Reichardt, 2003).”
BackgroundCREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134 · cited 2×
“Extensive studies have shown that CREB can be activated via phosphorylation at serine 133 by three signaling pathways: cAMP-PKA, Ca2 + -CaMKIV, and MAPK pathways (Shaywitz and Greenberg, 1999).”
Background
Cited by
Items 101–200 of 906
Hippocampal BDNF in physiological conditions and social isolation
Zaletel, I., Filipović, D., & Puškaš, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0072 · Cited by 110
“The possible link in the action of selective serotonin reuptake inhibitors, such as fluoxetine, and BDNF expression may lie in the activation, i.e. phosphorylation of CREB, which positively regulates BDNF transcription (Martinowich and Lu, 2007).”
BackgroundInfluentialBrain Changes Induced by Electroconvulsive Therapy Are Broadly Distributed
Ousdal, O. T., Árgyelán, M., Narr, K. L., Abbott, C., Wade, B., Vandenbulcke, M., Urretavizcaya, M., Tendolkar, I., Takamiya, A., Stek, M. L., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.07.010 · Cited by 115
“ECT may modulate the differentiation and function of serotonergic neurons through its effect on brain-derived neurotrophic factor levels (42,62).”
Mechanism of metformin regulation in central nervous system: Progression and future perspectives
Cao, G., Gong, T., Du, Y., Wang, Y., Ge, T., & Liu, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113686 · Cited by 116
NGF and BDNF: from nerves to adipose tissue, from neurokines to metabokines
Chaldarov, G. N., Tonchev, A. B., & Aloe, L. (2009) · Rivista di psichiatria · doi:10.1708/420.4977 · Cited by 115
Taleb, A., Lin, W., Xu, X., Zhang, G., Zhou, Q., Naveed, M., Meng, F. J., Fukunaga, K., & Han, F. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111322 · Cited by 112
The impact of HF-rTMS treatment on serotonin2A receptors in unipolar melancholic depression
Baeken, C., De Raedt, R., Bossuyt, A., Van Hove, C., Mertens, J., Dobbeleir, A., Blanckaert, P., & Goethals, I. (2011) · Brain Stimulation · doi:10.1016/j.brs.2010.09.002 · Cited by 101
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression
Bocchio‐Chiavetto, L., Miniussi, C., Zanardini, R., Gazzoli, A., Bignotti, S., Specchia, C., & Gennarelli, M. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.005 · Cited by 111
Hagena, H., & Manahan-Vaughan, D. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.06.014 · Cited by 97
“…due to its involvement in general physiological functions such as sleep and pain, but also because serotonin is connected to human diseases such as depression, schizophrenia and obsessive compulsive disorders (Filip & Bader, 2009; Martinowich & Lu, 2008; Nordquist & Oreland, 2010).”
Murínová, J., Hlaváčová, N., Chmelová, M., & Riečanský, I. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00101 · Cited by 110
“Serotonin signaling has an influence on BDNF gene transcription through altered activity of CREB, but also other transcription factors (Martinowich and Lu, 2008; Homberg et al., 2014).”
BackgroundBrain-derived neurotrophic factor and schizophrenia
Di Carlo, P., Punzi, G., & Ursini, G. (2019) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000237 · Cited by 110
“A remarkable number of studies in the last two decades demonstrate that BDNF is released at the synapse where it affects synaptic plasticity producing critical changes in cognitive functions, learning and memory (Lu and Martinowich, 2008; Nieto et al., 2013).”
BackgroundFrey, B. N., Lord, C., & Soares, C. N. (2008) · Menopause international · doi:10.1258/mi.2008.008019 · Cited by 111
Breuillaud, L., Rossetti, C., Meylan, E. M., Mérinat, C., Halfon, O., Magistretti, P. J., & Cardinaux, J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.011 · Cited by 111
Failla, M. D., Conley, Y. P., & Wagner, A. K. (2015) · Neurorehabilitation and neural repair · doi:10.1177/1545968315586465 · Cited by 110
“BDNF, a ubiquitously expressed neurotrophin in the brain, is an intriguing target for TBI intervention research due to its role in neuronal survival, neurogenesis, and plasticity.(11,12) However, in experimental TBI, acute infusions of BDNF did not improve motor, cognitive recovery or neuronal survival postinjury.”
BackgroundPurinergic receptors in psychiatric disorders
Krügel, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.032 · Cited by 109
“The possibility to exploit the transactivation pathway of A2A receptors to stimulate TrkB receptor signaling and thereby to improve BDNF functions is discussed (Martinowich and Lu, 2008; Wiese et al., 2007).”
Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia
Wong, J., Hyde, T. M., Cassano, H. L., Deep-Soboslay, A., Kleinman, J. E., & Weickert, C. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.037 · Cited by 91
BDNF Val66Met is Associated with Introversion and Interacts with 5-HTTLPR to Influence Neuroticism
Terracciano, A., Tanaka, T., Sutin, A. R., Deiana, B., Balaci, L., Sanna, S., Olla, N., Maschio, A., Uda, M., Ferrucci, L., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.213 · Cited by 94
“Infusion of BDNF into the brain increases activity in monoaminergic systems, whereas depletion of serotonin downregulates BDNF mRNA (Martinowich and Lu, 2008; Zhou et al, 2008).”
BackgroundInfluentialPremenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder
Takeda, T. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15484 · Cited by 108
“Brain derived neuro trophic factor (BDNF), which is essential for nerve cell growth, is thought to interact with serotonin systems in mood disorders.(60) The association of lower levels of BDNF and BDNF Val66Met polymorphism with increased risk for depression has been reported.”
BackgroundPharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?
Arranz, M. J., & Kapur, S. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn114 · Cited by 95
“Loss of the brain-derived neurotrophic factor (BDNF) from the hippocampus contributes to vulnerability for depression, whereas BDNF upregulation mediates antidepressant efficacy.(108,109) Several recent reports have linked polymorphisms in the BDNF gene with response to antidepressant and antipsychotic drugs (OR: 2.”
BackgroundThe Neuroendocrinology of Mood Disorders
Rubín, R. T., & Carroll, B. J. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00092-9 · Cited by 105
BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
Bazzari, A. H., & Bazzari, F. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158417 · Cited by 106
BDNF signaling is necessary for the antidepressant-like effect of naringenin
Yi, L., Liu, B., Li, J., Luo, L., Liu, Q., Geng, D., Tang, Y., Xia, Y. Z., & Wu, D. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.002 · Cited by 102
“Conversely, an increase in BDNF may result from the increased release of serotonin and/or norepinephrine, whichmay be a keymechanism underlying the therapeutic effects of antidepressants (Martinowich and Lu, 2008).”
Wang, A., Mi, L.-F., Zhang, Z.-L., Hu, M.-Z., Zhao, Z., Liu, B., Li, Y.-B., & Zheng, S. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113138 · Cited by 101
The Role of the GABAergic System in Diseases of the Central Nervous System
Zhang, W., Xiong, B., Zhang, L.-Q., Huang, X., Yuan, X., Tian, Y., & Tian, X. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.06.037 · Cited by 101
A Role for p11 in the Antidepressant Action of Brain-Derived Neurotrophic Factor
Warner-Schmidt, J. L., Chen, E. Y., Zhang, X., Marshall, J. J., Morozov, A., Svenningsson, P., & Greengard, P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.029 · Cited by 97
Leech, K. A., & Hornby, T. G. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2016.4532 · Cited by 101
“Use of antispastic agents, antidepressants, or other serotonergic agents within the past 2 weeks also excluded patients from participation secondary to the known effects of these medications on motor output,(44) locomotor function,(45) and BDNF expression.(46) All subjects obtained medical clearance and provided writt…”
BackgroundGrabe, H. J., Schwahn, C., Mahler, J., Appel, K., Schulz, A., Spitzer, C., Fenske, K., Barnow, S., Freyberger, H. J., Teumer, A., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.09.010 · Cited by 99
“Importantly, there are many lines of experimental evidence that demonstrate a functional interconnection between the serotonin system and BDNF, especially in neurogenesis and synaptic plasticity (Martinowich and Lu, 2008).”
BackgroundDalton, E. D., & Hammen, C. L. (2018) · Journal of Behavioral Medicine · doi:10.1007/s10865-018-9945-4 · Cited by 98
Liang, J., Wang, H., Zeng, Y., Qu, Y., Liu, Q., Zhao, F., Duan, J., Jiang, Y., Li, S., Ying, J., et al. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0099 · Cited by 81
Neuropeptides in depression: Role of VGF
Thakker-Varia, S., & Alder, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.006 · Cited by 86
“There is a positive, reciprocal interaction between BDNF expression and 5-HT, the major neurotransmitter implicated in the monoamine hypothesis [58].”
BackgroundHill, R. A., Wu, Y. W. C., Kwek, P., & Buuse, M. V. D. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2012.02277.x · Cited by 96
Theodoridi, A., Tsalafouta, A., & Pavlidis, M. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00223 · Cited by 95
“In addition, administration of selective serotonin reuptake inhibitors (SSRIs) resulted in increased bdnf gene expression (Martinowich and Lu, 2008).”
BackgroundRanuh, R., Fardah Athiyyah, A., Darma, A., Prasetyo Risky, V., Riawan, W., S. Surono, I., & Marto Sudarmo, S. (2019) · Iranian Journal of Microbiology · doi:10.18502/ijm.v11i2.1077 · Cited by 74
“BDNF is the most abundant and widely distributed growth factor in the CNS and is important for neuronal survival, migration, and differentiation; axonal and dendritic growth; synapse formation; regulation of synaptic plasticity and behaviour (1, 10, 14, 16, 22); and hippocampal neurogenesis (23).”
BackgroundKokkosis, A. G., Madeira, M. M., Hage, Z., Valais, K., Koliatsis, D., Resutov, E., & Tsirka, S. E. (2024) · Glia · doi:10.1002/glia.24464 · Cited by 84
“Importantly, these synaptic deficits were accompanied by substantial changes in the levels of BDNF, p-CREB, Table 1. and 5-HTR1A, all known regulatory signaling components involved in depressive disorders (Kaufman et al., 2015; Martinowich & Lu, 2008).”
BackgroundA meta-analysis of circulating BDNF concentrations in anorexia nervosa
Brandys, M. K., Kas, M. J. H., van Elburg, A. A., Campbell, I. C., & Adan, R. A. H. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.562244 · Cited by 85
“BDNF affects expression of other genes, including those in the dopaminergic (Berton et al. 2006), serotonergic (Martinowich and Lu 2007) and glutamatergic systems (Carvalho et al. 2008).”
BackgroundJafari, F., Amani, R., & Tarrahi, M. J. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01757-9 · Cited by 94
Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain, S., Rajput, A., Kumar, Y., Uppuluri, N., Arvind, A. S., & Tatu, U. S. (2005) · PubMed · Cited by 94
Uys, M. M., Shahid, M., & Harvey, B. H. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00144 · Cited by 91
Gupta, D., Kurhe, Y., & Radhakrishnan, M. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.02.036 · Cited by 89
“Previous studies have reported that stress decreases the brain serotonin levels while chronic antidepressant medications appear to produce their effects by increasing it [42,43].”
Gut microbiota regulates key modulators of social behavior
Parashar, A., & Udayabanu, M. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.002 · Cited by 88
Elwood, J., Murray, E. K., Bell, A. F., Sinclair, M., Kernohan, G. W., & Stockdale, J. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.059 · Cited by 88
Meylan, E. M., Halfon, O., Magistretti, P. J., & Cardinaux, J.-R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.012 · Cited by 87
“BDNF is also implicated in these processes, partly through the induction of its expression by CREB (Martinowich and Lu, 2008; Martinowich et al., 2007).”
Millard, S. J., Weston–Green, K., & Newell, K. A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.008 · Cited by 87
“While SSRIs cause acute elevations in serotonin concentrations, the antidepressant properties of SSRIs are largely thought to be elicited by downstream mechanisms, such as increases in brain derived neurotrophic factor (BDNF) and subsequent neurogenesis in the prefrontal cortex (PFC) and hippocampus (Martinowich and L…”
BackgroundInfluentialRéus, G. Z., Stringari, R. B., Ribeiro, K. F., Luft, T., Abelaira, H. M., Fries, G. R., Aguiar, B. W., Kapczinski, F., Hallak, J. E., Zuardi, A. W., et al. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00579.x · Cited by 86
“Nevertheless, there are relationships between the serotonin and BDNF (64,65).”
BackgroundMorshedi, M., Saghafi‐Asl, M., & Hosseinifard, E.-S. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-019-02169-y · Cited by 86
Effects of fluoxetine on fish: What do we know and where should we focus our efforts in the future?
Correia, D., Domingues, I., Faria, M., & Oliveira, M. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159486 · Cited by 86
GABAA Receptor Blockade Enhances Memory Consolidation by Increasing Hippocampal BDNF Levels
Kim, D. H., Kim, J. M., Park, S. J., Cai, M., Liu, X., Lee, S., Shin, C. Y., & Ryu, J. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.189 · Cited by 84
“Upon binding, BDNF-TrkB activation triggers a number of intracellular signaling pathways (Martinowich and Lu, 2008) and in turn, de novo protein synthesis related to c-fos or zif268 gene expression, which participates in synaptic plasticity and memory consolidation (Alder et al, 2003; Jones et al, 2001; Yasoshima et a…”
BackgroundVitale, R. M., Iannotti, F. A., & Amodeo, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094876 · Cited by 84
“In turn, 5-HT upregulates BDNF expression levels [30].”
BackgroundEarly life stress as an influence on limbic epilepsy: a hypothesis whose time has come?
Koe, A. S., Jones, N. C., & Salzberg, M. R. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.024.2009 · Cited by 82
“SSRIs moderate HPA activity in depressed patients and in animal models (Schule, 2007); and they have well-established effects on hippocampal neurogenesis which may underlie their antidepressant effect (Duman and Monteggia, 2006) and which also are mediated via the 5-HT 1A receptor (Martinowich and Lu, 2008).”
BackgroundFrontal and subcortical grey matter reductions in PTSD
O'Doherty, D. C. M., Tickell, A. M., Ryder, W., Chan, C., Hermens, D. F., Bennett, M. R., & Lagopoulos, J. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.05.008 · Cited by 81
“These treatment therapies have been shown, over time, to slow or reverse grey matter atrophy caused by glutamate neurotoxicity, in addition to promoting neurogenesis through increasing BDNF (Levy-Gigi et al., 2013; Martinowich and Lu, 2008).”
BackgroundRupanagunta, G. P., Nandave, M., Rawat, D., Upadhyay, J., Rashid, S., & Ansari, M. N. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.05.008 · Cited by 81
Hlaváčová, N., Bakoš, J., & Ježová, D. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109106955 · Cited by 82
“As mentioned above, alterations in brain plasticity and a dysregulation of neuroendocrine stress system have been suggested to be common denominators of stress-related mental disorders (Holsboer, 2000; Martinowich and Lu, 2008).”
BackgroundA Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia
Nurjono, M., Lee, J., & Chong, S.-A. (2012) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2012.10.2.61 · Cited by 75
Dionisie, V., Ciobanu, A. M., Toma, V. A., Manea, M. C., Baldea, I., Olteanu, D., Sevastre-Berghian, A., Clichici, S., Manea, M., Riga, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147483 · Cited by 78
NPY and its involvement in axon guidance, neurogenesis, and feeding
Hökfelt, T. G. M., Stanić, D., Sanford, S. D., Gatlin, J. C., Nilsson, I. A. K., Paratcha, G., Ledda, F., Fetissov, S. O., Lindfors, C., Herzog, H., et al. (2008) · Nutrition · doi:10.1016/j.nut.2008.06.010 · Cited by 78
Understanding epigenetic architecture of suicide neurobiology: A critical perspective
Roy, B., & Dwivedi, Y. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.031 · Cited by 69
“…abnormal gene expression or impaired mature protein processing and transportation may give rise to serious pathological conditions abrogating the entire cellular pathway related to plasticity (Autry and Monteggia, 2012; Lipsky and Marini, 2007; Martinowich and Lu, 2008; Martinowich et al., 2007).”
BackgroundComasco, E., Hahn, A., Ganger, S., Gingnell, M., Bannbers, E., Oreland, L., Wikström, J., Epperson, C. N., Lanzenberger, R. R., & Poromaa, I. S. (2014) · Human Brain Mapping · doi:10.1002/hbm.22486 · Cited by 76
“A constellation of molecular, pharmacological and genetic findings support an interaction between 5-HT and BDNF with implication for mood disorders [Martinowich and Lu, 2008].”
BackgroundInfluentialCosta, M.-A., Girard, M. F., Dalmay, F., & Malauzat, D. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01548.x · Cited by 79
“, 2002), with depression and anxiety (Marticnowich and Lu, 2008), with Parkinson’s disease (Parain et al.”
BackgroundFanaei, H., Khayat, S., Kasaeian, A., & Javadimehr, M. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.11.003 · Cited by 76
Chen, L., Pan, H., Tuan, T. A., Teh, A. L., MacIsaac, J. L., Mah, S. M., McEwen, L. M., Li, Y., Chen, H., Broekman, B. F. P., et al. (2015) · Development and Psychopathology · doi:10.1017/s0954579414001357 · Cited by 75
“…interaction effects of BDNF Val66Met and the SLC6A4 polymorphism on serotonin-dependent emotional states such as depression (Kim et al., 2007; Martinowich & Lu, 2008), obsessive–compulsive disorder (Wendland, Kruse, Cromer, & Murphy, 2007) and a three-way interaction effect of BDNF Val66Met,…”
BackgroundComasco, E., Sylvén, S. M., Papadopoulos, F. C., Oreland, L., Poromaa, I. S., & Skalkidou, A. (2011) · Archives of Women s Mental Health · doi:10.1007/s00737-011-0239-x · Cited by 75
“The BDNF system plays a regulatory role in many neuronal functions including neurogenesis and synaptic plasticity (Martinowich and Lu 2008).”
BackgroundInfluentialRegulation of myelin genes implicated in psychiatric disorders by functional activity in axons
Lee, P. R., & Fields, R. D. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.004.2009 · Cited by 76
“Interactions between BDNF and serotonin in mood disorders have been reported (Martinowich and Lu, 2008), and the BDNF gene has been associated with increased risk for a number of neuropsychiatric disorders (Martinowich et al.”
Dretsch, M. N., Williams, K., Emmerich, T., Crynen, G. C., Ait‐Ghezala, G., Chaytow, H., Mathura, V. S., Crawford, F., & Iverson, G. L. (2015) · Brain and Behavior · doi:10.1002/brb3.392 · Cited by 75
“These findings, in conjunction with BDNF polymorphisms having strong association in the literature with synaptic plasticity (Martinowich and Lu 2008) and mood disorders (Montag et al. 2010) imply an association with increased risk of PTSD. Combat exposure as a predictor of traumatic stress in…”
Resilience and vulnerability are dose-dependently related to neonatal stressors in mice
Macrì, S., Granstrem, O., Shumilina, M. V., Santos, F. J., Berry, A., Saso, L., & Laviola, G. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.07.006 · Cited by 74
“Together, these data support the view that BDNF downregulation may exert a prominent role in the aetiology of affective disorders (Martinowich and Lu, 2008).”
BackgroundOddone, F., Roberti, G., Micera, A., Busanello, A., Bonini, S., Quaranta, L., Agnifili, L., & Manni, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168565 · Cited by 74
Fullana, M. N., Ruiz‐Bronchal, E., Ferrés‐Coy, A., Juárez‐Escoto, E., Artigas, F., & Bortolozzi, A. A. (2019) · Glia · doi:10.1002/glia.23593 · Cited by 76
Ruhé, H. G., Booij, J., Weert, H. C. V., Reitsma, J. B., Fransen, E. J. F., Michel, M. C., & Schene, A. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.148 · Cited by 73
“Many adaptive pre- and postsynaptic effects of chronic administration of SSRIs have been documented, including neuroadaptive alterations in serotonin receptors and intracellular signaling pathways (Blendy, 2006; Kim et al, 2002; Meyer et al, 2001a; Davidson and Stamford, 2000; Benmansour et al, 1999; Blier and De Mont…”
BackgroundDiabetes-associated depression: The serotonergic system as a novel multifunctional target
Gupta, D., Prabhakar, V., Kanade, P., & Radhakrishnan, M. (2015) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.150305 · Cited by 73
“[36] Furthermore, BDNF and other neuropeptides have been found to be involved in the regulation of 5-HT system.[37] One of the most direct involvements of the GC in BDNF regulation is the modulation of BDNF transcription by binding of GC on the glucocorticoid response element in the promoter regions.”
BackgroundNeonatal levels of neurotrophic factors and risk of autism spectrum disorders
Abdallah, M. W., Mortensen, E. L., Greaves‐Lord, K., Larsen, N., Bonefeld‐Jørgensen, E. C., Nørgaard‐Pedersen, B., Hougaard, D. M., & Grove, J. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12020 · Cited by 72
“Moreover, abundant evidence suggests changes in neurotransmitter levels in ASD (21), and NTFs have been shown to affect levels of different neurotransmitters, including serotonin (22), dopamine (23), and acetylcholine (24).”
BackgroundEker, M. C., Kitis, O., Okur, H., Eker, O. D., Ozan, E., Isikli, S., Akarsu, N., & Gonul, A. S. (2011) · Neuropsychobiology · doi:10.1159/000321834 · Cited by 68
Neurotrophic factors in obsessive-compulsive disorder
Fontenelle, L. F., Barbosa, I. G., Luna, J. V., Rocha, N. P., de Miranda, A. S., & Teixeira, A. L. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.034 · Cited by 73
“Of note, BDNF, NGF and GDNF and have been shown to interact reciprocally with different circuits and neurotransmitters, including 5HT (Martinowich and Lu, 2008), DA (Carnicella and Ron, 2009), and acetylcholine (ACh) (Cirulli and Alleva, 2009) systems, respectively .”
Boyarskikh, U. A., Bondar, N. P., Филипенко, М. Л., & Kudryavtseva, N. N. (2011) · Nature Precedings · doi:10.1007/s12035-013-8413-y · Cited by 72
“Research evidence shows that BDNF promotes the survival and differentiation of 5-HT neurons [58].”
BackgroundAlboni, S., Benatti, C., Capone, G., Corsini, D., Caggia, F., Tascedda, F., Mendlewicz, J., & Brunello, N. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.028 · Cited by 61
“It has been postulated that the prefrontal cortex and the hippocampus are key sites where ADs exert their therapeutic effects by affecting the serotonergic system (Mayberg, 2003; Martinowich and Lu, 2008).”
BackgroundMethodInfluentialAkyuz, E., Arulsamy, A., Aslan, F. S., Sarisözen, B., Guney, B., Hekimoglu, A., Yilmaz, B. N., Retinasamy, T., & Shaikh, M. F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04333-y · Cited by 69
“BDNF, TRKB, and 5-HT are co-expressed in the median and dorsal raphe of the brain [178].”
Román, P., Carrillo-Trabalón, F., Sánchez‐Labraca, N., Cañadas, F., Estévez, Á. F., & Cardona, D. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0125 · Cited by 69
Neurotrophic gene polymorphisms and response to psychological therapy
Lester, K. J., Hudson, J. L., Tropeano, M., Creswell, C., Collier, D. A., Farmer, A., Lyneham, H. J., Rapee, R. M., & Eley, T. C. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.33 · Cited by 62
Additive gene-environment effects on hippocampal structure in healthy humans
Rabl, U., Meyer, B. M., Diers, K., Bartova, L., Berger, A., Mandorfer, D., Popovic, A., Scharinger, C., Huemer, J., Kalcher, K., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3113-13.2014 · Cited by 68
“Accordingly, the observed effects could be driven by both direct and indirect serotonergic effects, including 5-HTTLPR-mediated alterations of HPA axis activity or direct effects of serotonin on neuroplasticity (Martinowich and Lu, 2008; Klempin et al., 2013; Miller et al., 2013).”
BackgroundThe Neuroscience of Resilience
Hunter, R. G., Gray, J. D., & McEwen, B. S. (2018) · Journal of the Society for Social Work and Research · doi:10.1086/697956 · Cited by 68
Park, S.-A., Son, S. Y., Lee, A.-Y., Park, H.-G., Lee, W.-L., & Lee, C. H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17020541 · Cited by 68
Gardiner, J., Barton, D., Overall, R., & Marc, J. (2009) · The Neuroscientist · doi:10.1177/1073858408325269 · Cited by 62
“Activation of the serotonin receptor 5-HT(1A) protects against H2O2-induced oxidative stress including caspase-3 activation in mice (Narita and others 2005), and selective serotonin reuptake inhibitors (SSRIs) increase BDNF expression (Martinowich and Lu 2008).”
BackgroundSalami, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.613120 · Cited by 67
“Through different signaling pathways, the psychobiotics play an important role in controlling the neural excitatory inhibitory balance, mood, cognitive functions and, learning and memory processes (Heldt et al., 2007; Lu et al., 2008; Martinowich and Lu, 2008).”
BackgroundMertens, L. J., & Preller, K. H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1341-1907 · Cited by 65
“Notably, an interaction between 5-HT and BDNF levels has been reported, with BDNF promoting survival and differentiation of 5-HT neurons, and antidepressant medication enhancing BDNF gene expression [29].”
BackgroundNeuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes
Lu, W., & Wen, J. (2025) · Aging and disease · doi:10.14336/ad.2024.0214-1 · Cited by 54
“BDNF levels in sera of patients are increased after antidepressants treatment, containing SSRIs, monoamine oxidase inhibitors, tricyclic agents, serotonin‐norepinephrine reuptake inhibitors, as well as including specific serotonergic antidepressants [161-163].”
Developing ‘integrative’ zebrafish models of behavioral and metabolic disorders
Nguyen, M., Yang, E., Neelkantan, N., Mikhaylova, A., Arnold, R., Poudel, M. K., Stewart, A., & Kalueff, A. V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.012 · Cited by 67
Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments
Richardson, B., MacPherson, A., & Bambico, F. R. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100554 · Cited by 66
“Further, SSRIs have been shown to increase BDNF related processes (Martinowich and Lu, 2008).”
BackgroundSaxena, S., & Hillis, A. E. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1373020 · Cited by 67
“It may also increase brainderived neurotropic factor (BDNF) levels [124], which is thought to be critical in modulating stroke recovery in humans.”
BackgroundAntidepressant-Like Effects of Gyejibokryeong-hwan in a Mouse Model of Reserpine-Induced Depression
Park, B.-K., Kim, Y. R., Kim, Y. H., Yang, C., Seo, C., Jung, I. C., Jang, I., Kim, S., & Lee, M. Y. (2018) · BioMed Research International · doi:10.1155/2018/5845491 · Cited by 67
“The concentration of plasma serotonin, a key regulator of emotions and mood disorders [25], was significantly decreased in control mice following reserpine administration (control: 37.”
BackgroundPottoo, F. H., Javed, M. N., Barkat, M. A., Alam, M. S., Nowshehri, J. A., Alshayban, D., & Ansari, M. A. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180628164432 · Cited by 66
Ignácio, Z. M., Réus, G. Z., Abelaira, H. M., & Quevedo, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.036 · Cited by 65
Pilar‐Cuéllar, F., Vidal, R., & Pazos, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01516.x · Cited by 59
“It is noteworthy that BDNF is mainly involved in synaptic plasticity, rather than in neuron growth and survival (see Martinowich and Lu, 2008).”
BackgroundSabb, F. W., Burggren, A. C., Higier, R. G., Fox, J., He, J., Parker, D. S., Poldrack, R. A., Chu, W., Cannon, T. D., Freimer, N. B., et al. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.013 · Cited by 58
“Abnormal BDNF expression has been observed in patients with schizophrenia (Lu and Martinowich, 2008) and mood disorders (Martinowich et al., 2007; Martinowich and Lu, 2008).”
BackgroundEhrlich, S., Salbach-Andrae, H., Eckart, S., Merle, J. V., Burghardt, R., Pfeiffer, E., Franke, L., Uebelhack, R., Lehmkuhl, U., & Hellweg, R. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0942 · Cited by 50
“Further studies suggest that 5-HT transmission exerts powerful control over BDNF expression.(29) There is only limited ex-vivo evidence for the interrelations of the neurotrophin and the 5-HT system in humans.”
BackgroundDukhinova, M., Kuznetsova, I. S., Kopeikina, E., Veniaminova, E. A., Yung, A. W. Y., Veremeyko, T., Levchuk, K., Barteneva, N. S., Wing-Ho, K. K., Yung, W., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.009 · Cited by 66
State and trait characteristics of early course major depressive disorder
van Eijndhoven, P. (2012) · Radboud Repository (Radboud University) · Cited by 73
Wang, Y., Mathews, C. A., Li, Y., Lin, Z., & Xiao, Z. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.002 · Cited by 64
“Several studies have shown that BDNF promotes the survival, differentiation and regeneration sprouting of serotonergic neurons both in culture and in vivo (Eaton and Whittemore, 1996; Mamounas et al., 2000; Martinowich and Lu, 2008).”
BackgroundVinberg, M., Trajkovska, V., Bennike, B., Knorr, U., Knudsen, G. M., & Kessing, L. V. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.014 · Cited by 65
Texel, S. J., Camandola, S., Ladenheim, B., Rothman, S. M., Mughal, M. R., Unger, E. L., Cadet, J. L., & Mattson, M. P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07554.x · Cited by 58
“Moreover, both 5HT (Martinowich and Lu 2008) and NE (Chen et al.”
BackgroundInfluentialGrabe, H. J., Schwahn, C., Mahler, J., Schulz, A., Spitzer, C., Fenske, K., Appel, K., Barnow, S., Nauck, M., Schomerus, G., et al. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32027 · Cited by 56
“Especially the serotonergic system plays an important role in brain development, in neurogenesis and synaptic plasticity and interacts, for example, with the brain-derived neurotrophic factor (BDNF) [Martinowich and Lu, 2008;Grabe et al., 2012].”
BackgroundComasco, E., Åslund, C., Oreland, L., & Nilsson, K. W. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.01.010 · Cited by 63
“With regard to antidepressant responses, selective serotonin reuptake inhibitors have been shown to enhance the BDNF gene expression (Martinowich and Lu, 2008), and an epistatic effect between 5-HTTLPR and BDNF Val66Met has been shown in response to lithium treatment (Rybakowski et al., 2007), and…”
InfluentialWilloughby, M. T., Mills-Koonce, R., Propper, C. B., & Waschbusch, D. A. (2013) · Development and Psychopathology · doi:10.1017/s0954579413000266 · Cited by 52
“It is noteworthy that BDNF and 5-HTT act in a synergistic fashion and have been implicated in the development of affective disorders (Henningsson et al., 2009; Martinowich & Lu, 2008).”
BackgroundCenci, M. A., Ohlin, K. E., & Ottosson, D. R. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70782-5 · Cited by 63
“This has been clearly demonstrated to be the case for antidepressant pharmacotherapies (partially reviewed in [27,28]).”
BackgroundInfluential
Metadata
- Authors
- Martinowich, K., & Lu, B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Lu, Bai
- Venue
- Neuropsychopharmacology
- Published
- 2007-09-19
- Volume
- 33
- Issue
- 1
- Pages
- 73-83
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2067657652
- Cited by
- 793
- References
- 133
- Citations by year
- 2026: 34 · 2025: 42 · 2024: 48 · 2023: 38 · 2022: 58 · 2021: 67 · 2020: 52 · 2019: 54 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 39 · 2014: 36 · 2013: 36 · 2012: 43
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- brain-derived neurotrophic factor, serotonin, mood disorders, depression, anxiety, selective serotonin reuptake inhibitors, antidepressant effects, synaptic plasticity, neurogenesis, serotonergic neurons, serotonin transporter, genetic epistasis, emotional behavior
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Neurons, Serotonin, Brain-Derived Neurotrophic Factor, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.